Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 630, pseudogene (RNU6-630P)
- Target
- RNU6-630P
- Molecular classification
- Pseudogene, Non-coding RNA, Small nuclear RNA-derived pseudogene
01
Overview
RNU6-630P, or RNA, U6 small nuclear 630, pseudogene, is a human genome locus classified as a pseudogene derived from the U6 small nuclear RNA gene family[2]. The parent molecule, U6 snRNA, is an integral component of the spliceosome complex, playing an essential role in precursor mRNA splicing by facilitating intron excision within the nucleus[3][5]. U6 snRNA itself is highly conserved and crucial to the splicing process, but pseudogenes like RNU6-630P result from retrotransposition events or genomic duplications and do not produce functional RNA[7][1]. While these pseudogenes are no longer functional, their presence in the genome can reflect the activity of retrotransposition mechanisms—especially those mediated by LINE-1 elements—or act as evolutionary markers. RNU6-630P is not a protein, receptor, enzyme, or factor involved in cell signaling, and it does not have therapeutic relevance as a direct drug target[2][7].
- Other names
- RNU6-630P
02
Biological functions
Serves as a genomic marker of retrotransposition activity; does not encode functional RNA
03
Disease associations
Not implicated as a direct participant in disease; may be used as a marker in studies of genome evolution or retrotransposition
04
Biomarkers
May serve as a biomarker for retrotransposition dynamics in genomic studies, but not for clinical patient selection or drug monitoring
Beyond the preview
Go deeper on RNA, U6 small nuclear 630, pseudogene (RNU6-630P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNA, U6 small nuclear 630, pseudogene (RNU6-630P).